Last reviewed · How we verify

NCT04858373

Characterizing Emmer Seeds and Flours, and Determining the Glycemic Effects of Emmer Breads

Completed NA Last updated 26 April 2021
What this trial tests

NA trial testing Glucose as reference food in Potential Abnormality of Glucose Tolerance in 14 participants. Completed in 1 November 2019.

Timeline
1 August 2019
Primary endpoint
1 November 2019
1 November 2019

Quick facts

Lead sponsorAgricultural University of Athens
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment14
Start date1 August 2019
Primary completion1 November 2019
Estimated completion1 November 2019
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Agricultural University of Athens

Who can join

Adults 18 to 25, any sex, with Potential Abnormality of Glucose Tolerance or Appetitive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study characterized emmer seeds, flours, and breads, and investigated the effects of emmer breads on the glycemic response

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Glucose as reference food

Trials testing the same drug.

Other Agricultural University of Athens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04858373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing